Type 2 diabetes

• Novo Nordisk’s CagriSema outperforms Ozempic in Phase III trial - While the drug also previously succeeded in two obesity studies, it fell short of expectations at the time.
• FDA Approves Oral Version of Wegovy, First GLP-1 Pill Approved Specifically for Weight Management - The pill is expected to be available starting in January 2026.